SCHEMBL6340609

SCHEMBL6340609

C=C1C=C(C)CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12956159 0.73
SCHEMBL8505903 0.71
SCHEMBL31473494 0.67
SCHEMBL9945764 0.67
SCHEMBL6538235 0.67
SCHEMBL9613581 0.67
SCHEMBL19062835 0.67
SCHEMBL124901 0.67
SCHEMBL3132799 0.67
SCHEMBL18942790 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010005738-A1 Building blocks containing isocyanate groups and their use for functionalizing or modifying compounds or surfaces BASF AKTIENGESELLSCHAFT (DE) 2001-06-28 US claimed
US-6913629-B2 Building blocks containing isocyanate groups and their use for functionalizing or modifying compounds or surfaces BASF AKTIENGESELLSCHAFT (DE) 2005-07-05 US disclosed
EP-1381593-A2 (2-HYDROXY)ETHYL-THIOUREAS USEFUL AS MODULATORS OF ALPHA2B ADRENERGIC RECEPTORS Allergan, Inc. (US) 2004-01-21 EP disclosed
US-6534542-B2 For alleviating chronic pain and allodynia and have no or only minimal cardivascular and/or sedatory activity ALLERGEN SALES, INC. 2003-03-18 US disclosed
US-20020161051-A1 (2-hydroxy)ethyl-thioureas useful as modulators of alpha2B adrenergic receptors ALLERGAN SALES, INC. 2002-10-31 US disclosed
WO-2002068384-A2 (2-HYDROXY)ETHYL-THIOUREAS USEFUL AS MODULATORS OF ALPHA2B ADRENERGIC RECEPTORS ALLERGAN, INC. (US) 2002-09-06 WO disclosed
US-20010005738-A1 Building blocks containing isocyanate groups and their use for functionalizing or modifying compounds or surfaces BASF AKTIENGESELLSCHAFT (DE) 2001-06-28 US disclosed